advertisement
PURPOSE: To evaluate long-term IOP control after sutureless clear corneal phacoemulsification in eyes with preoperatively controlled glaucoma. SETTING: Institutional study. METHODS: The charts of 345 patients who had uneventful sutureless clear corneal phacoemulsification with acrylic foldable lens (IOL) implantation were retrospectively reviewed. Included were 58 patients with medically controlled open-angle glaucoma and 287 normal controls. Follow-up was 1 to 2 years. Outcome measures were postoperative IOP and number of glaucoma medications. RESULTS: Postoperatively, there was an insignificant decrease in IOP in the glaucoma group; the mean decrease was 1.5 mmHg ± 4.4 (SD) at 12 months and 1.9 ± 4.9 mmHg at 24 months. The mean number of medications decreased significantly at 12 months (0.53 ± 0.86) and at 24 months (0.38 ± 0.9) (P= .04). The control group also had a significant decrease in IOP, with a mean decrease of 0.72 ± 3.7 mmHg at 12 months (P= .01) and 1.33 ± 3.2 mmHg at 24 months (P < .0001). The decrease in IOP was more pronounced in eyes with a higher preoperative IOP in both the glaucoma and control groups. CONCLUSIONS: These findings suggest that sutureless clear corneal phacoemulsification with foldable acrylic IOL implantation is a relatively simple and efficient surgical option in patients with cataract and well-controlled glaucoma. The approach combines long-term IOP control with fewer medications and leads to rapid visual rehabilitation.
Dr. N. Mathalone, Department of Ophthalmology, Carmel Medical Center, Haifa, Israel.
12.14.3 Phacoemulsification (Part of: 12 Surgical treatment > 12.14 Combined cataract extraction and glaucoma surgery)